These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 6344327

  • 21. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R, Creutzfeldt W, Ebert R, Becker HD, Börger HW, Schafmayer A.
    Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
    [Abstract] [Full Text] [Related]

  • 22. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL.
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [Abstract] [Full Text] [Related]

  • 23. Failure of fasting to influence the GIP response to oral glucose in non-obese human subjects.
    Andrews WJ, Henry RW, Alam MJ, Alberti KG, Buchanan KD.
    Diabetologia; 1983 Oct; 25(4):372-4. PubMed ID: 6357919
    [Abstract] [Full Text] [Related]

  • 24. Effect of exogenous insulin on fasting serum levels of gastric inhibitory polypeptide (GIP) in juvenile diabetes.
    Talaulicar M, Ebert R, Willms B, Creutzfeldt W.
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):175-80. PubMed ID: 7021006
    [Abstract] [Full Text] [Related]

  • 25. Increased plasma response of gastric inhibitory polypeptide to oral glucose and a liquid meal after prolonged starvation in healthy man.
    Oektedalen O, Opstad PK, Jorde R.
    Digestion; 1983 Feb; 26(3):114-23. PubMed ID: 6343163
    [Abstract] [Full Text] [Related]

  • 26. Glucose-dependent insulin-releasing peptide in noninsulin-dependent maturity-onset diabetes: effects of autonomic neuropathy.
    Levitt NS, Vinik AI, Child PT.
    J Clin Endocrinol Metab; 1980 Aug; 51(2):254-8. PubMed ID: 6995476
    [Abstract] [Full Text] [Related]

  • 27. The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.
    Takemura J, Seino Y, Yamamura T, Yoshiya K, Ishikawa Y, Itoh N, Imura H.
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):345-53. PubMed ID: 6354520
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
    Creutzfeldt W, Talaulicar M, Ebert R, Willms B.
    Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats.
    Hampton SM, Kwasowski P, Tan K, Morgan LM, Marks V.
    Diabetologia; 1983 Apr; 24(4):278-81. PubMed ID: 6345248
    [Abstract] [Full Text] [Related]

  • 31. Diminished gastric inhibitory polypeptide response to oral glucose in late human pregnancy.
    Hornnes PJ, Kühl C, Lauritsen KB.
    J Clin Endocrinol Metab; 1979 Mar; 48(3):506-8. PubMed ID: 429501
    [Abstract] [Full Text] [Related]

  • 32. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R.
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [Abstract] [Full Text] [Related]

  • 33. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ, Rizza RA, Westland RE, Hall LD, Gerich JE, Go VL.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [Abstract] [Full Text] [Related]

  • 34. [The effect of calcium on the release of gastric inhibitory polypeptide (GIP) - with reference to the release of GIP in patients with hyperparathyroidism (author's transl)].
    Nakanome C, Akai H, Umezu M, Toyota T, Goto Y, Furukawa Y, Sato T, Yumita S, Bloom SR.
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb 20; 58(2):98-109. PubMed ID: 7044844
    [Abstract] [Full Text] [Related]

  • 35. [Gastric inhibitory polypeptide (GIP) (author's transl].
    Ebert R, Finke U.
    Z Gastroenterol; 1978 May 20; 16(5):311-6. PubMed ID: 654387
    [Abstract] [Full Text] [Related]

  • 36. Effects of diet on insulin and gastric inhibitory polypeptide levels in obese children.
    Deschamps I, Heptner W, Desjeux JF, Baltakse V, Machinot S, Lestradet H.
    Pediatr Res; 1980 Apr 20; 14(4 Pt 1):300-3. PubMed ID: 6990366
    [Abstract] [Full Text] [Related]

  • 37. The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls.
    Jorde R, Schulz TB, Burhol PG, Schulz LB.
    Regul Pept; 1981 Nov 20; 2(6):391-9. PubMed ID: 7029674
    [Abstract] [Full Text] [Related]

  • 38. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
    Cataland S, O'Dorisio TM, Crockett SE, Mekhjian HS.
    J Clin Endocrinol Metab; 1978 Sep 20; 47(3):615-9. PubMed ID: 400727
    [Abstract] [Full Text] [Related]

  • 39. Gastrointestinal insulinotropic hormones in normal and gestational-diabetic pregnancy: response to oral glucose.
    Hornnes PJ, Kühl C, Lauritsen KB.
    Diabetes; 1981 Jun 20; 30(6):504-9. PubMed ID: 7014314
    [Abstract] [Full Text] [Related]

  • 40. Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.
    Sarson DL, Kopelman PG, Besterman HS, Pilkington TR, Bloom SR.
    Diabetologia; 1983 Nov 20; 25(5):386-91. PubMed ID: 6360777
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.